KEGG   DRUG: CelmoleukinHelp
Entry
D02743                      Drug                                   

Name
Celmoleukin (genetical recombination) (JP17);
Celmoleukin (INN);
Celeuk (TN)
Formula
C693H1118N178O203S7
Exact mass
15406.0677
Mol weight
15415.8178
Remark
Therapeutic category: 6399
Efficacy
Antineoplastic, Immunostimulant, Biological response modifier
Comment
recombinant interleukin 2 [HSA:3558] [KO:K05429]
Target
IL2RA (CD25) [HSA:3559] [KO:K05068]
IL2RB (CD122) [HSA:3560] [KO:K05069]
IL2RG (CD132) [HSA:3561] [KO:K05070]
  Pathway
hsa04060  Cytokine-cytokine receptor interaction
hsa04630  Jak-STAT signaling pathway
Brite
Therapeutic category of drugs in Japan [BR:br08301]
 6  Agents against pathologic organisms and parasites
  63  Biological preparations
   639  Miscellaneous
    6399  Others
     D02743  Celmoleukin (genetical recombination) (JP17); Celmoleukin (INN)
Target-based classification of drugs [BR:br08310]
 Cytokines and receptors
  Cytokine receptors
   Interleukin receptors
    IL2RA (CD25)
     D02743  Celmoleukin (genetical recombination) (JP17)
    IL2RB (CD122)
     D02743  Celmoleukin (genetical recombination) (JP17)
    IL2RG (CD132)
     D02743  Celmoleukin (genetical recombination) (JP17)
Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
 Chemicals
  D02743  Celmoleukin (genetical recombination)
BRITE hierarchy
Other DBs
CAS: 94218-72-1
PubChem: 17396906

» Japanese version   » Back

DBGET integrated database retrieval system